Amyloid Biomarkers in Conformational Diseases at Face Value: A Systematic Review

Conformational diseases represent a new aspect of proteomic medicine where diagnostic and therapeutic paradigms are evolving. In this context, the early biomarkers for target cell failure (neurons, β-cells, etc.) represent a challenge to translational medicine and play a multidimensional role as bio...

Full description

Saved in:
Bibliographic Details
Published in:Molecules (Basel, Switzerland) Switzerland), 2017-12, Vol.23 (1), p.79
Main Authors: Avila-Vazquez, Maria Fernanda, Altamirano-Bustamante, Nelly F, Altamirano-Bustamante, Myriam M
Format: Article
Language:English
Subjects:
Alzheimer’s disease
Amyloid - metabolism
amyloid oligomers
Animals
biomarker
Biomarkers
Biomarkers - analysis
Chaperones
conformational diseases
cytotoxic oligomers
diabetes mellitus
Diagnostic systems
Disease
Enzyme-Linked Immunosorbent Assay
Humans
Immunoassays
Multidimensional methods
Pharmacology
Protein Aggregates
Protein Conformation
Review
Systematic review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c493t-a974d6307dfced6235f73ba5c2054d2b9efefeef79eb2756e2c3557f798034d43
cites cdi_FETCH-LOGICAL-c493t-a974d6307dfced6235f73ba5c2054d2b9efefeef79eb2756e2c3557f798034d43
container_end_page
container_issue 1
container_start_page 79
container_title Molecules (Basel, Switzerland)
container_volume 23
creator Avila-Vazquez, Maria Fernanda
Altamirano-Bustamante, Nelly F
Altamirano-Bustamante, Myriam M
description Conformational diseases represent a new aspect of proteomic medicine where diagnostic and therapeutic paradigms are evolving. In this context, the early biomarkers for target cell failure (neurons, β-cells, etc.) represent a challenge to translational medicine and play a multidimensional role as biomarkers and potential therapeutic targets. This systematic review, which follows the PICO and Prisma methods, analyses this new-fangled multidimensionality, its strengths and limitations, and presents the future possibilities it opens up. The nuclear diagnosis methods are immunoassays: ELISA, immunodot, western blot, etc., while the therapeutic approach is focused on pharmaco- and molecular chaperones.
doi_str_mv 10.3390/molecules23010079
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_7aa7b93a59984bf69f8261d7890bbf18</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_7aa7b93a59984bf69f8261d7890bbf18</doaj_id><sourcerecordid>1982840246</sourcerecordid><originalsourceid>FETCH-LOGICAL-c493t-a974d6307dfced6235f73ba5c2054d2b9efefeef79eb2756e2c3557f798034d43</originalsourceid><addsrcrecordid>eNplkV1vFCEUhifGxn7oD_DGkHjjzSqfA3hhsq5WmzRp49ctYZhDZWWGCjNt9t_Lum3Targ4cHjPkxfepnlO8GvGNH4zpAhujlAowwRjqR81B4RTvGCY68f39vvNYSlrjCnhRDxp9qmmqmVUHzTny2ETU-jR-5AGm39BLiiMaJVGn_Jgp5BGG9GHUMAWKMhO6Ng6QD9snOEtWqKvmzLBVufQF7gKcP202fM2Fnh2U4-a78cfv60-L07PPp2slqcLxzWbFlZL3rcMy9476FvKhJess8JRLHhPOw2-LvBSQ0elaIE6JoSsZ4UZ7zk7ak523D7ZtbnMobrfmGSD-dtI-cLYXG1FMNJa2WlmhdaKd77VXtGW9FJp3HWeqMp6t2Ndzt0AvYNxyjY-gD68GcNPc5GuTIuJFFpUwKsbQE6_ZyiTGUJxEKMdIc3FEK2o4pjytkpf_iNdpznXTy6G1oAUxVpuHZGdyuVUSgZ_Z4Zgs83e_Jd9nXlx_xV3E7dhsz-i5Kyd</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2002820978</pqid></control><display><type>article</type><title>Amyloid Biomarkers in Conformational Diseases at Face Value: A Systematic Review</title><source>Publicly Available Content (ProQuest)</source><source>PubMed</source><creator>Avila-Vazquez, Maria Fernanda ; Altamirano-Bustamante, Nelly F ; Altamirano-Bustamante, Myriam M</creator><creatorcontrib>Avila-Vazquez, Maria Fernanda ; Altamirano-Bustamante, Nelly F ; Altamirano-Bustamante, Myriam M</creatorcontrib><description>Conformational diseases represent a new aspect of proteomic medicine where diagnostic and therapeutic paradigms are evolving. In this context, the early biomarkers for target cell failure (neurons, β-cells, etc.) represent a challenge to translational medicine and play a multidimensional role as biomarkers and potential therapeutic targets. This systematic review, which follows the PICO and Prisma methods, analyses this new-fangled multidimensionality, its strengths and limitations, and presents the future possibilities it opens up. The nuclear diagnosis methods are immunoassays: ELISA, immunodot, western blot, etc., while the therapeutic approach is focused on pharmaco- and molecular chaperones.</description><identifier>ISSN: 1420-3049</identifier><identifier>EISSN: 1420-3049</identifier><identifier>DOI: 10.3390/molecules23010079</identifier><identifier>PMID: 29286329</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Alzheimer’s disease ; Amyloid - metabolism ; amyloid oligomers ; Animals ; biomarker ; Biomarkers ; Biomarkers - analysis ; Chaperones ; conformational diseases ; cytotoxic oligomers ; diabetes mellitus ; Diagnostic systems ; Disease ; Enzyme-Linked Immunosorbent Assay ; Humans ; Immunoassays ; Multidimensional methods ; Pharmacology ; Protein Aggregates ; Protein Conformation ; Review ; Systematic review</subject><ispartof>Molecules (Basel, Switzerland), 2017-12, Vol.23 (1), p.79</ispartof><rights>Copyright MDPI AG 2018</rights><rights>2017 by the authors. 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c493t-a974d6307dfced6235f73ba5c2054d2b9efefeef79eb2756e2c3557f798034d43</citedby><cites>FETCH-LOGICAL-c493t-a974d6307dfced6235f73ba5c2054d2b9efefeef79eb2756e2c3557f798034d43</cites><orcidid>0000-0001-7297-4689</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2002820978/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2002820978?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25752,27923,27924,37011,37012,44589,53790,53792,74897</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29286329$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Avila-Vazquez, Maria Fernanda</creatorcontrib><creatorcontrib>Altamirano-Bustamante, Nelly F</creatorcontrib><creatorcontrib>Altamirano-Bustamante, Myriam M</creatorcontrib><title>Amyloid Biomarkers in Conformational Diseases at Face Value: A Systematic Review</title><title>Molecules (Basel, Switzerland)</title><addtitle>Molecules</addtitle><description>Conformational diseases represent a new aspect of proteomic medicine where diagnostic and therapeutic paradigms are evolving. In this context, the early biomarkers for target cell failure (neurons, β-cells, etc.) represent a challenge to translational medicine and play a multidimensional role as biomarkers and potential therapeutic targets. This systematic review, which follows the PICO and Prisma methods, analyses this new-fangled multidimensionality, its strengths and limitations, and presents the future possibilities it opens up. The nuclear diagnosis methods are immunoassays: ELISA, immunodot, western blot, etc., while the therapeutic approach is focused on pharmaco- and molecular chaperones.</description><subject>Alzheimer’s disease</subject><subject>Amyloid - metabolism</subject><subject>amyloid oligomers</subject><subject>Animals</subject><subject>biomarker</subject><subject>Biomarkers</subject><subject>Biomarkers - analysis</subject><subject>Chaperones</subject><subject>conformational diseases</subject><subject>cytotoxic oligomers</subject><subject>diabetes mellitus</subject><subject>Diagnostic systems</subject><subject>Disease</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Humans</subject><subject>Immunoassays</subject><subject>Multidimensional methods</subject><subject>Pharmacology</subject><subject>Protein Aggregates</subject><subject>Protein Conformation</subject><subject>Review</subject><subject>Systematic review</subject><issn>1420-3049</issn><issn>1420-3049</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNplkV1vFCEUhifGxn7oD_DGkHjjzSqfA3hhsq5WmzRp49ctYZhDZWWGCjNt9t_Lum3Targ4cHjPkxfepnlO8GvGNH4zpAhujlAowwRjqR81B4RTvGCY68f39vvNYSlrjCnhRDxp9qmmqmVUHzTny2ETU-jR-5AGm39BLiiMaJVGn_Jgp5BGG9GHUMAWKMhO6Ng6QD9snOEtWqKvmzLBVufQF7gKcP202fM2Fnh2U4-a78cfv60-L07PPp2slqcLxzWbFlZL3rcMy9476FvKhJess8JRLHhPOw2-LvBSQ0elaIE6JoSsZ4UZ7zk7ak523D7ZtbnMobrfmGSD-dtI-cLYXG1FMNJa2WlmhdaKd77VXtGW9FJp3HWeqMp6t2Ndzt0AvYNxyjY-gD68GcNPc5GuTIuJFFpUwKsbQE6_ZyiTGUJxEKMdIc3FEK2o4pjytkpf_iNdpznXTy6G1oAUxVpuHZGdyuVUSgZ_Z4Zgs83e_Jd9nXlx_xV3E7dhsz-i5Kyd</recordid><startdate>20171229</startdate><enddate>20171229</enddate><creator>Avila-Vazquez, Maria Fernanda</creator><creator>Altamirano-Bustamante, Nelly F</creator><creator>Altamirano-Bustamante, Myriam M</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-7297-4689</orcidid></search><sort><creationdate>20171229</creationdate><title>Amyloid Biomarkers in Conformational Diseases at Face Value: A Systematic Review</title><author>Avila-Vazquez, Maria Fernanda ; Altamirano-Bustamante, Nelly F ; Altamirano-Bustamante, Myriam M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c493t-a974d6307dfced6235f73ba5c2054d2b9efefeef79eb2756e2c3557f798034d43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Alzheimer’s disease</topic><topic>Amyloid - metabolism</topic><topic>amyloid oligomers</topic><topic>Animals</topic><topic>biomarker</topic><topic>Biomarkers</topic><topic>Biomarkers - analysis</topic><topic>Chaperones</topic><topic>conformational diseases</topic><topic>cytotoxic oligomers</topic><topic>diabetes mellitus</topic><topic>Diagnostic systems</topic><topic>Disease</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Humans</topic><topic>Immunoassays</topic><topic>Multidimensional methods</topic><topic>Pharmacology</topic><topic>Protein Aggregates</topic><topic>Protein Conformation</topic><topic>Review</topic><topic>Systematic review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Avila-Vazquez, Maria Fernanda</creatorcontrib><creatorcontrib>Altamirano-Bustamante, Nelly F</creatorcontrib><creatorcontrib>Altamirano-Bustamante, Myriam M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Molecules (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Avila-Vazquez, Maria Fernanda</au><au>Altamirano-Bustamante, Nelly F</au><au>Altamirano-Bustamante, Myriam M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Amyloid Biomarkers in Conformational Diseases at Face Value: A Systematic Review</atitle><jtitle>Molecules (Basel, Switzerland)</jtitle><addtitle>Molecules</addtitle><date>2017-12-29</date><risdate>2017</risdate><volume>23</volume><issue>1</issue><spage>79</spage><pages>79-</pages><issn>1420-3049</issn><eissn>1420-3049</eissn><abstract>Conformational diseases represent a new aspect of proteomic medicine where diagnostic and therapeutic paradigms are evolving. In this context, the early biomarkers for target cell failure (neurons, β-cells, etc.) represent a challenge to translational medicine and play a multidimensional role as biomarkers and potential therapeutic targets. This systematic review, which follows the PICO and Prisma methods, analyses this new-fangled multidimensionality, its strengths and limitations, and presents the future possibilities it opens up. The nuclear diagnosis methods are immunoassays: ELISA, immunodot, western blot, etc., while the therapeutic approach is focused on pharmaco- and molecular chaperones.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>29286329</pmid><doi>10.3390/molecules23010079</doi><orcidid>https://orcid.org/0000-0001-7297-4689</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1420-3049
ispartof Molecules (Basel, Switzerland), 2017-12, Vol.23 (1), p.79
issn 1420-3049
1420-3049
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_7aa7b93a59984bf69f8261d7890bbf18
source Publicly Available Content (ProQuest); PubMed
subjects Alzheimer’s disease
Amyloid - metabolism
amyloid oligomers
Animals
biomarker
Biomarkers
Biomarkers - analysis
Chaperones
conformational diseases
cytotoxic oligomers
diabetes mellitus
Diagnostic systems
Disease
Enzyme-Linked Immunosorbent Assay
Humans
Immunoassays
Multidimensional methods
Pharmacology
Protein Aggregates
Protein Conformation
Review
Systematic review
title Amyloid Biomarkers in Conformational Diseases at Face Value: A Systematic Review
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T08%3A14%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Amyloid%20Biomarkers%20in%20Conformational%20Diseases%20at%20Face%20Value:%20A%20Systematic%20Review&rft.jtitle=Molecules%20(Basel,%20Switzerland)&rft.au=Avila-Vazquez,%20Maria%20Fernanda&rft.date=2017-12-29&rft.volume=23&rft.issue=1&rft.spage=79&rft.pages=79-&rft.issn=1420-3049&rft.eissn=1420-3049&rft_id=info:doi/10.3390/molecules23010079&rft_dat=%3Cproquest_doaj_%3E1982840246%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c493t-a974d6307dfced6235f73ba5c2054d2b9efefeef79eb2756e2c3557f798034d43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2002820978&rft_id=info:pmid/29286329&rfr_iscdi=true